1. Home
  2. IDN vs ELTX Comparison

IDN vs ELTX Comparison

Compare IDN & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDN
  • ELTX
  • Stock Information
  • Founded
  • IDN 1994
  • ELTX 2011
  • Country
  • IDN United States
  • ELTX United States
  • Employees
  • IDN N/A
  • ELTX N/A
  • Industry
  • IDN Computer Software: Prepackaged Software
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IDN Technology
  • ELTX Health Care
  • Exchange
  • IDN Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • IDN 120.5M
  • ELTX 121.7M
  • IPO Year
  • IDN 1999
  • ELTX N/A
  • Fundamental
  • Price
  • IDN $5.35
  • ELTX $7.72
  • Analyst Decision
  • IDN Strong Buy
  • ELTX Strong Buy
  • Analyst Count
  • IDN 3
  • ELTX 2
  • Target Price
  • IDN $5.83
  • ELTX $9.50
  • AVG Volume (30 Days)
  • IDN 481.3K
  • ELTX 57.8K
  • Earning Date
  • IDN 08-07-2025
  • ELTX 08-12-2025
  • Dividend Yield
  • IDN N/A
  • ELTX N/A
  • EPS Growth
  • IDN N/A
  • ELTX N/A
  • EPS
  • IDN N/A
  • ELTX N/A
  • Revenue
  • IDN $20,211,000.00
  • ELTX N/A
  • Revenue This Year
  • IDN $9.35
  • ELTX N/A
  • Revenue Next Year
  • IDN $13.05
  • ELTX N/A
  • P/E Ratio
  • IDN N/A
  • ELTX N/A
  • Revenue Growth
  • IDN 4.55
  • ELTX N/A
  • 52 Week Low
  • IDN $1.92
  • ELTX $3.34
  • 52 Week High
  • IDN $6.49
  • ELTX $9.99
  • Technical
  • Relative Strength Index (RSI)
  • IDN 59.07
  • ELTX 55.57
  • Support Level
  • IDN $5.21
  • ELTX $7.70
  • Resistance Level
  • IDN $5.97
  • ELTX $8.19
  • Average True Range (ATR)
  • IDN 0.39
  • ELTX 0.36
  • MACD
  • IDN -0.10
  • ELTX -0.09
  • Stochastic Oscillator
  • IDN 29.01
  • ELTX 19.05

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: